A feasibility study of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with epithelial ovarian carcinoma, fallopian tube carcinoma or peritoneal carcinoma.
(13th International Gynecologic Cancer Society 2010)